- Home
- EDSA vs LIFW Comparison
EDSA vs LIFW Comparison
Compare EDSA & LIFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- LIFW
- Stock Information
- Founded
- EDSA 2015
- LIFW 2014
- Country
- EDSA Canada
- LIFW United States
- Employees
- EDSA N/A
- LIFW 88
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- LIFW Computer Software: Prepackaged Software
- Sector
- EDSA Health Care
- LIFW Technology
- Exchange
- EDSA Nasdaq
- LIFW Nasdaq
- Market Cap
- EDSA 6.1M
- LIFW 6.2M
- IPO Year
- EDSA N/A
- LIFW N/A
- Fundamental
- Price
- EDSA $1.89
- LIFW $3.24
- Analyst Decision
- EDSA Strong Buy
- LIFW
- Analyst Count
- EDSA 1
- LIFW 0
- Target Price
- EDSA $21.00
- LIFW N/A
- AVG Volume (30 Days)
- EDSA 31.2K
- LIFW 3.3M
- Earning Date
- EDSA 02-07-2025
- LIFW 11-14-2024
- Dividend Yield
- EDSA N/A
- LIFW N/A
- EPS Growth
- EDSA N/A
- LIFW N/A
- EPS
- EDSA N/A
- LIFW N/A
- Revenue
- EDSA N/A
- LIFW $10,734,000.00
- Revenue This Year
- EDSA N/A
- LIFW $293,208.70
- Revenue Next Year
- EDSA N/A
- LIFW N/A
- P/E Ratio
- EDSA N/A
- LIFW N/A
- Revenue Growth
- EDSA N/A
- LIFW 217.86
- 52 Week Low
- EDSA $1.69
- LIFW $1.43
- 52 Week High
- EDSA $5.99
- LIFW $82.50
- Technical
- Relative Strength Index (RSI)
- EDSA 37.11
- LIFW 47.30
- Support Level
- EDSA $1.73
- LIFW $1.56
- Resistance Level
- EDSA $2.55
- LIFW $2.38
- Average True Range (ATR)
- EDSA 0.18
- LIFW 0.47
- MACD
- EDSA 0.03
- LIFW 0.05
- Stochastic Oscillator
- EDSA 25.58
- LIFW 18.96
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About LIFW MSP Recovery Inc.
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.